Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine.

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst said, and could mean weak earnings for ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Tata Motors, Nykaa, Ola Electric, Hi-Tech Pipes, and More - Heres a quick recap of stocks that are likely to attract ...

Increasing investment in adult immunisation has the potential to deliver $1.1 billion in benefits every year, according to a new report commissioned ...

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

GSK Australia Media ReleaseIncreasing investment in adult immunisation has the potential to deliver $1.1 billion in benefits ...

Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

Lockheed Martin (LMT) and the U.S. Department of Defense reach agreement on F-35 upgrades, potential $500 million payment.